Eligibility Criteria below apply only to the patient. (The patient's partner must be 18 years of age or older.)  Patient Inclusion Criteria:  Age ≥18 female with a history of any stage breast and/or gynecological cancer. Completed primary treatment (chemotherapy, radiation and/or surgery) ≥ 3 months and ≤ 5 years prior to registration. May use concurrent adjuvant endocrine therapy or HER2-targeted therapy while on study. Responds yes to the question "Has there been change in communication and/or intimacy with your partner since your cancer diagnosis?" Ability to read and write English. A stable partner, defined as anyone with whom the woman has had an intimate relationship with for at least 3 months prior to her cancer diagnosis. Both partner and woman must agree to participate in the study and sign informed consent to the study.  Patient Exclusion Criteria:  Antidepressants are allowed if a person has been on them for 30 days prior to registration, and dose or treatment is not expected to change. Past history of sexual abuse. Psychiatric disorder such as major depressive disorder, bipolar disorder, obsessive compulsive disorder or schizophrenia. (Defined per medical history and/or patient self-report.) Currently enrolled in another study that addresses sexual health (enrollment in other clinical trials will be allowed).